Your browser doesn't support javascript.
Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study.
Cascini, Silvia; Agabiti, Nera; Marino, Claudia; Acampora, Anna; Balducci, Maria; Calandrini, Enrico; Davoli, Marina; Bargagli, Anna Maria.
  • Cascini S; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
  • Agabiti N; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
  • Marino C; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
  • Acampora A; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
  • Balducci M; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
  • Calandrini E; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
  • Davoli M; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
  • Bargagli AM; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.
J Alzheimers Dis ; 89(2): 681-693, 2022.
Article in English | MEDLINE | ID: covidwho-1974611
ABSTRACT

BACKGROUND:

The identification of risk factors for SARS-CoV-2 infection and mortality in patients with dementia is a key aspect to support clinical decisions and public health interventions.

OBJECTIVE:

To assess the incidence of SARS-CoV-2 infection and COVID-19 related death in a cohort of patients with dementia residing in the Lazio region and to investigate predicting factors for both infection and mortality.

METHODS:

This population-based study used information from administrative databases and the SARS-CoV-2 infection surveillance system. Patients with dementia (age ≥65) were enrolled as of December 31, 2019 and followed-up until February 28, 2021. Cumulative risk of infection and death within 60 days of infection onset, and age-standardized incidence (SIR) and mortality (SMR) ratios were calculated. Logistic regression models were applied to identify factors associated with infection and mortality.

RESULTS:

Among 37,729 dementia patients, 2,548 had a diagnosis of SARS-CoV-2 infection. The crude risk of infection was 6.7%. An increase in risk of infection was observed both in women (SIR 1.72; 95% CI 1.64-1.80) and men (SIR 1.43; 95% CI 1.33-1.54). Pneumonia, cerebrovascular and blood diseases, femur fracture, anxiety, antipsychotic and antithrombotic use were associated with an increased risk of infection. The crude risk of death was 31.0%, the SMRs 2.32 (95% CI 2.05-2.65) for men, and 2.82 (95% CI 2.55-3.11) for women. Factors associated with mortality included male gender, age ≥85, symptoms at the diagnosis, antipsychotic and systemic antibiotics treatment.

CONCLUSION:

These findings emphasize the need of close and tailored monitoring of dementia patients to reduce the impact of COVID-19 on this fragile population.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antipsychotic Agents / Dementia / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male Language: English Journal: J Alzheimers Dis Journal subject: Geriatrics / Neurology Year: 2022 Document Type: Article Affiliation country: JAD-220369

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antipsychotic Agents / Dementia / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male Language: English Journal: J Alzheimers Dis Journal subject: Geriatrics / Neurology Year: 2022 Document Type: Article Affiliation country: JAD-220369